NCT06275334招募中不适用
Dinutuximab Beta at the Strasbourg University Hospitals (HUS) and the Toulouse Oncopole: Comparative Analysis of Patient Pathways, Associated Costs and Quality of Life According to Traditional Hospitalization or Hospital at Home (HAD)
University Hospital, Strasbourg, France1 个研究点 分布在 1 个国家目标入组 40 人开始时间: 2023年11月28日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 40
- 试验地点
- 1
- 主要终点
- Comparison of two methods of treating a pediatric pathology in two French health establishments, the HUS and the Oncopole of Toulouse.
研究概览
简要总结
In this study the investigators wish to describe the cohort of pediatric patients suffering from neuroblastoma and treated with Dinutuximab and to compare the costs and quality of life between the two French centers, the University Hospital of Strasbourg (HUS) and the Oncopole of Toulouse.
研究设计
- 研究类型
- Observational
- 观察模型
- Case Only
- 时间视角
- Retrospective
入排标准
- 年龄范围
- 2 Years 至 25 Years（Child, Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Subjects aged 2 years to 25 years
- •Male or female gender
- •Subjects suffering from neuroblastoma and treated at the HUS or at the Oncopole center in Toulouse during the period from January 1, 1998 to December 31,
- •Subject (and/or holders of parental authority) not opposing, after information, the reuse of the child's data for the purposes of this research and agreeing to respond to the quality of life survey.
排除标准
- •Patient or parents of the minor having expressed their opposition to participating in the study.
- •specific clinical forms of the disease,
- •interfering treatments and associated diseases.
结局指标
主要结局
Comparison of two methods of treating a pediatric pathology in two French health establishments, the HUS and the Oncopole of Toulouse.
时间窗: The period concerned is from January 1, 1998 to December 31, 2023.
This study is retrospective and consists of comparing two methods of treating neuroblastoma in two health establishments and covers the period from January 1, 1998 to December 31, 2023.
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
3 期
A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD)Lung Diseases, InterstitialNCT04093024Boehringer Ingelheim39
招募中
2 期
Brentuximab Vedotin for Newly Diagnosed CHL in Chinese CAYA Based on PET/CT AssessmentTreatmentBrentuximab VedotinPET ScanClassical Hodgkin LymphomaChildAdolescentYoung AdultMetabolic ResponseSurvivalNCT06563245Children's Cancer Group, China96
终止
2 期
A Study to Evaluate the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of Orally Administered Lumicitabine (JNJ-64041575) Regimens in Hospitalized Infants and Children Aged 28 Days to 36 Months Infected With Respiratory Syncytial VirusRespiratory Syncytial VirusesNCT03333317Janssen Research & Development, LLC7
撤回
2 期
Study of Imatinib in Children With Neurofibromatosis and Airway TumorsNeurofibroma, PlexiformNCT03688568Indiana University
已完成
2 期
Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform NeurofibromasPlexiform NeurofibromaNeurofibromatosis Type 1NCT03231306University of Alabama at Birmingham45